Both in Pharmaceuticals
Anixa Biosciences vs Equillium
Over the past year ANIX returned −24.6% and EQ returned −11.6%; their daily moves had a correlation of 0.15.
ANIX −24.6% EQ −11.6%Growth of $1, one year, split-adjusted
| Metric | ANIX | EQ |
|---|---|---|
| Price | $3.12 | $1.37 |
| Market cap | $108.5M | $107.4M |
| Today | −5.45% | −3.52% |
| 1 month | +12.6% | −11.0% |
| 6 months | −0.6% | −34.1% |
| Year to date | 0.0% | −11.6% |
| 1 year | −25.0% | 0.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $13.9M | $57.2M |
| Dividend yield | — | — |
| Volatility (60d) | 58.9% | 90.0% |
| Short % of float | 7.4% | 12.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).